-
Diagnostics World |Droplet Bioscience’s validated clinical test analyzes post-surgical lymphatic fluid for circulating tumor DNA. In a process sped up by NVIDIA Parabricks, the test can provide adjuvant-informing results in about a week.
Mar 11, 2026
-
Diagnostics World News | The healthcare industry has a weight problem—a weight bias problem, according to Ashley Koff, RD, founder of The Better Nutrition Program. During her plenary keynote at February’s Integrative Healthcare Symposium, Koff addressed the urgent need to rethink approaches to weight, metabolic health, and the use of GLP-1 medications.
Mar 10, 2026
-
Diagnostics World News | At February’s Integrative Healthcare Symposium, Dr. George Schatz urged clinicians to rethink how they evaluate long COVID. For patients who still struggle with long-term fatigue, brain fog, palpitations, and sleep disruption, he proposed a diagnostics-first framework that prioritizes mechanism over labels.
Mar 5, 2026
-
Diagnostics World News | The vast number and diversity of chemicals that exist in the natural world represent both the cause of and solution to all the world’s problems. As such, they are foundational, high-stakes agents irrespective of the biological system—be they comprised of plants, microorganisms, or human beings.
Mar 4, 2026
-
Diagnostics World News | The quest to marry different DNA methylation technologies for the purpose of early cancer detection has been ongoing for several decades now. Among the recent breakthroughs is an “epigenetic instability index” (EII) measuring the randomness of methylation rather than just consistent, fixed changes.
Mar 3, 2026
-
Diagnostics World News | Sanofi appoints Belén Garijo as chief executive officer; PacBio collaborates with iHope; Astoriom acquires Precision Stability Storage, expanding its sample management capabilities in the U.S.; and more.
Feb 26, 2026
-
Diagnostics World News | Neogap Therapeutics advances their ongoing clinical study for personalized therapy for advanced colorectal cancer; Syndex Bio introduced its proprietary mcPCR (methyl-copying PCR) platform; and more.
Feb 25, 2026
-
Diagnostics World News | Precision medicine is often described as the future of healthcare. But from an engineering standpoint, it’s already here, and it’s forcing diagnostic instruments to evolve faster than most development cycles are comfortable with. We’re asking instruments to do more than confirm a suspected diagnosis. We’re asking them to deliver specificity, speed, and confidence in environments that aren’t always predictable. That’s a major shift from the days when “good enough” screening could drive clinical decisions.
Feb 20, 2026